Harte Hanks Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Harte Hanks.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Media croissance des bénéfices	13.5%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Recent updates

Investors Aren't Entirely Convinced By Harte Hanks, Inc.'s (NASDAQ:HHS) Revenues

Jul 03

With EPS Growth And More, Harte Hanks (NASDAQ:HHS) Makes An Interesting Case

Nov 03

Harte Hanks, Inc.'s (NASDAQ:HHS) Intrinsic Value Is Potentially 30% Above Its Share Price

Oct 13

If EPS Growth Is Important To You, Harte Hanks (NASDAQ:HHS) Presents An Opportunity

Oct 27

Harte Hanks: Good Point To Start Accumulation Again (Technical Analysis)

Sep 27

Harte Hanks (NASDAQ:HHS) Could Become A Multi-Bagger

Sep 19

Harte Hanks and FEVO announce expanding partnership

Sep 15

Harte Hanks: Mean Reversion Imminent, But Still A Buy For Patient Investors

Aug 23

Harte Hanks, Inc. (NASDAQ:HHS) Stock Catapults 25% Though Its Price And Business Still Lag The Market

Aug 13

Harte Hanks GAAP EPS of $0.52 beats by $0.24, revenue of $48.6M misses by $0.7M

Aug 11

What Does Harte Hanks, Inc.'s (NASDAQ:HHS) Share Price Indicate?

Jul 26

Harte Hanks: This Top-Rated Micro-Cap Stock Has A Great Growth Potential

Jul 14

Harte-Hanks: Deep Valuation And Future Growth Could Double The Stock

May 23

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Harte Hanks n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

NasdaqGM:HHS - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
9/30/2024	188	-30	-7	-3	N/A
6/30/2024	187	-29	-1	2	N/A
3/31/2024	190	-1	0	3	N/A
12/31/2023	191	-2	8	10	N/A
9/30/2023	197	23	11	13	N/A
6/30/2023	204	29	20	24	N/A
3/31/2023	204	32	26	31	N/A
12/31/2022	206	35	23	29	N/A
9/30/2022	203	14	20	26	N/A
6/30/2022	199	12	7	13	N/A
3/31/2022	200	17	-1	3	N/A
12/31/2021	195	13	-5	-2	N/A
9/30/2021	190	12	-6	-2	N/A
6/30/2021	188	7	-9	-5	N/A
3/31/2021	180	-8	-12	-10	N/A
12/31/2020	177	-2	-11	-8	N/A
9/30/2020	182	-6	-11	-9	N/A
6/30/2020	186	-11	-12	-11	N/A
3/31/2020	199	-9	8	11	N/A
12/31/2019	218	-27	9	12	N/A
9/30/2019	235	-22	4	7	N/A
6/30/2019	248	-26	0	4	N/A
3/31/2019	263	-28	-19	-15	N/A
12/31/2018	285	15	-13	-9	N/A
9/30/2018	314	-16	0	4	N/A
6/30/2018	345	-8	N/A	14	N/A
3/31/2018	370	-5	N/A	-27	N/A
12/31/2017	384	-42	N/A	-31	N/A
9/30/2017	394	-85	N/A	-54	N/A
6/30/2017	397	-86	N/A	-49	N/A
3/31/2017	400	-90	N/A	9	N/A
12/31/2016	404	-90	N/A	15	N/A
9/30/2016	411	-18	N/A	32	N/A
6/30/2016	423	-188	N/A	28	N/A
3/31/2016	434	-187	N/A	18	N/A
12/31/2015	444	-181	N/A	33	N/A
9/30/2015	474	-170	N/A	36	N/A
6/30/2015	499	9	N/A	41	N/A
3/31/2015	530	22	N/A	39	N/A
12/31/2014	499	14	N/A	26	N/A
9/30/2014	559	21	N/A	43	N/A
6/30/2014	560	19	N/A	41	N/A
3/31/2014	560	20	N/A	54	N/A
12/31/2013	560	24	N/A	60	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de HHS est supérieure au taux d'épargne ( 2.6% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de HHS devraient croître plus rapidement que le marché US

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de HHS devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de HHS devraient croître plus rapidement que le marché US.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de HHS devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de HHS devrait être élevé dans 3 ans

Harte Hanks Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Price target decreased by 13% to US$20.00

Consensus EPS estimates fall by 46%

Price target increased by 9.5% to US$23.00

Consensus EPS estimates increase by 14%

Price target increased to US$21.00

Price target increased to US$20.00

Recent updates

Harte Hanks, Inc. to Report Q3, 2024 Results on Nov 14, 2024

Harte Hanks, Inc Announces Executive Changes

Harte Hanks, Inc. Appoints Sharona Sankar-King as Chief Customer and Data Officer

Harte Hanks, Inc. to Report Q2, 2024 Results on Aug 08, 2024

Harte Hanks, Inc.(NasdaqGM:HHS) dropped from Russell Microcap Value Index

Investors Aren't Entirely Convinced By Harte Hanks, Inc.'s (NASDAQ:HHS) Revenues

Harte Hanks Launches Demand Generation in a Box

CEO & Director recently bought US$50k worth of stock

First quarter 2024 earnings released: US$0.024 loss per share (vs US$0.11 loss in 1Q 2023)

Harte Hanks, Inc. to Report Q1, 2024 Results on May 09, 2024

Harte Hanks, Inc., Annual General Meeting, May 23, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Harte Hanks, Inc. to Report Q4, 2023 Results on Mar 14, 2024

Harte Hanks, Inc. Appoints Luke Kenny as Sr. Director of International Sales and Client Expansion

Harte Hanks, Inc. Appoints David Fisher as Chief Transformation Officer

Harte Hanks, Inc. Appoints David Garrison as Permanent Chief Financial Officer

Less than half of directors are independent

Independent Director recently bought US$68k worth of stock

New major risk - Revenue and earnings growth

Third quarter 2023 earnings: EPS and revenues miss analyst expectations

Harte Hanks, Inc. Names Ron Lee as Senior Vice President of Inside Sales

With EPS Growth And More, Harte Hanks (NASDAQ:HHS) Makes An Interesting Case

Harte Hanks, Inc. to Report Q3, 2023 Results on Nov 09, 2023

Harte Hanks, Inc. Appoints Kelly Waller as Senior Vice President of Sales and Marketing

Harte Hanks Announces Executive Changes

Harte Hanks, Inc.'s (NASDAQ:HHS) Intrinsic Value Is Potentially 30% Above Its Share Price

Now 23% undervalued

CEO & Director recently bought US$51k worth of stock

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Harte Hanks, Inc. to Report Q2, 2023 Results on Aug 10, 2023

Harte Hanks Inc. Appoints Kirk Davis as Member of the Board of Directors

Harte Hanks (NASDAQ:HHS) Is Experiencing Growth In Returns On Capital

Harte Hanks, Inc. Elects Genni Combes as Board Nominee

Price target decreased by 13% to US$20.00

Consensus EPS estimates fall by 46%

Harte Hanks, Inc. (NasdaqGM:HHS) announces an Equity Buyback for 10% of its issued share capital, for $6.5 million.

First quarter 2023 earnings: EPS and revenues miss analyst expectations

Price target increased by 9.5% to US$23.00

Should You Investigate Harte Hanks, Inc. (NASDAQ:HHS) At US$8.83?

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Does Harte Hanks (NASDAQ:HHS) Deserve A Spot On Your Watchlist?

CEO & Director recently bought US$56k worth of stock

Are Investors Undervaluing Harte Hanks, Inc. (NASDAQ:HHS) By 22%?

Harte Hanks, Inc. (NasdaqGM:HHS) acquired Substantially all the assets of Inside Out Solutions LLC for $7.5 million.

Consensus EPS estimates increase by 14%

Price target increased to US$21.00

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Harte Hanks, Inc. to Report Q3, 2022 Results on Nov 10, 2022

If EPS Growth Is Important To You, Harte Hanks (NASDAQ:HHS) Presents An Opportunity

Harte Hanks: Good Point To Start Accumulation Again (Technical Analysis)

Harte Hanks (NASDAQ:HHS) Could Become A Multi-Bagger

Investor sentiment deteriorated over the past week

Harte Hanks and FEVO announce expanding partnership

Harte Hanks: Mean Reversion Imminent, But Still A Buy For Patient Investors

Independent Director recently sold US$1.2m worth of stock

Harte Hanks, Inc. (NASDAQ:HHS) Stock Catapults 25% Though Its Price And Business Still Lag The Market

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Harte Hanks GAAP EPS of $0.52 beats by $0.24, revenue of $48.6M misses by $0.7M

Harte Hanks, Inc. to Report Q2, 2022 Results on Aug 11, 2022

What Does Harte Hanks, Inc.'s (NASDAQ:HHS) Share Price Indicate?

Investor sentiment improved over the past week

Harte Hanks: This Top-Rated Micro-Cap Stock Has A Great Growth Potential

Price target increased to US$20.00

Harte-Hanks: Deep Valuation And Future Growth Could Double The Stock

Harte Hanks, Inc. to Report Q1, 2022 Results on May 12, 2022

Harte Hanks, Inc., Annual General Meeting, May 23, 2022

Harte Hanks, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Harte Hanks Common Stock Deleted from Other OTC

Harte Hanks, Inc., Annual General Meeting, Jun 23, 2021